These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7554324)

  • 41. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
    MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
    Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
    Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
    Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duration of angiotensin-converting enzyme inhibition: implications for tolerability.
    Murray NH
    Cardiology; 1991; 79 Suppl 1():22-9. PubMed ID: 1655262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin converting enzyme inhibitors.
    Breckenridge A
    Br Med J (Clin Res Ed); 1988 Feb; 296(6622):618-20. PubMed ID: 2832034
    [No Abstract]   [Full Text] [Related]  

  • 49. Moexipril versus captopril in patients with mild to moderate hypertension.
    Stimpel M; Koch B; Jansen T; Fox A; Loh I
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):769-73. PubMed ID: 8961074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Angioneurotic edema caused by angiotensin-converting enzyme inhibitors: incidence, clinical characteristics, mechanisms of action].
    Wernze H
    Z Kardiol; 1988; 77 Suppl 3():61-4. PubMed ID: 2850689
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
    Vertes V; Haynie R
    Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cough induced by enalapril but not by captopril.
    Puolijoki H; Nieminen M; Moilanen E; Siitonen L; Lahdensuo A; Reinikainen P; Vapaatalo H
    Eur Respir J; 1989 Mar; 2(3):289-91. PubMed ID: 2543598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The treatment of mild to moderate hypertension with ACE inhibitors.
    Taylor SH
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S; Luna A; Orozco R; Velasco G
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of captopril and enalapril on zinc metabolism in hypertensive patients.
    Golik A; Zaidenstein R; Dishi V; Blatt A; Cohen N; Cotter G; Berman S; Weissgarten J
    J Am Coll Nutr; 1998 Feb; 17(1):75-8. PubMed ID: 9477394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dermatitis to captopril.
    Martínez JC; Fuentes MJ; Armentia A; Vega JM; Fernández A
    Allergol Immunopathol (Madr); 2001; 29(6):279-80. PubMed ID: 11834188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension].
    De Cesaris R; Ranieri G; Andriani A; Chiarappa R
    Minerva Med; 1990; 81(7-8):541-6. PubMed ID: 2166253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.